Interestingly, a recent study demonstrated that miR-221 expression was regulated by RelB-p52 complex of the NFκB signaling pathway to which drug resistant MM cells are suggested to be addicted [47]. The gene discussed is RELB; the disease is Miyoshi myopathy.